Silverback Therapeutics, Inc. SBTX

SBTX Quotes by TradingView
Institutional shares held 47.9 Million
442K calls
42K puts
Total value of holdings $0
$0 calls
$0 puts
Market Cap N/A
Institutional ownership 135.0%
# of Institutions 116

Quarterly Institutional Activity in SBTX

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding SBTX

View all
View all

Latest Institutional Activity in SBTX

Top Purchases

Q1 2024
Ra Capital Management, L.P. Shares Held: 10.9M ($0)
1.4M Shares purchased
14.81% Added
Q1 2024
State Street Corp Shares Held: 1.6M ($0)
1.03M Shares purchased
178.09% Added
Q1 2024
Perceptive Advisors LLC Shares Held: 867K ($0)
867K Shares purchased
New Holding
Q1 2024
Vanguard Group Inc Shares Held: 2.89M ($0)
780K Shares purchased
37.03% Added
Q1 2024
Invesco Ltd. Shares Held: 411K ($0)
397K Shares purchased
2726.33% Added
View All Buyers

Top Sells

Q1 2024
Franklin Resources Inc Shares Held: 2.95M ($0)
1.15M Shares sold
28.0% Reduced
Q1 2024
K2 Principal Fund, L.P. Shares Held: 2.22M ($0)
835K Shares sold
27.34% Reduced
Q1 2024
Sio Capital Management, LLC Shares Held: 536K ($0)
570K Shares sold
51.52% Reduced
Q1 2024
Woodline Partners LP Shares Held: 402K ($0)
260K Shares sold
39.25% Reduced
Q1 2024
Susquehanna International Group, LLP Shares Held: 80.8K ($0)
173K Shares sold
68.1% Reduced
View All Sellers

About SBTX

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

SBTX Chart by TradingView
SBTX Fundamental Data by TradingView

Insider Transactions at SBTX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
May 16 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
89,096 -2.6%
$801,864 $9.06 P/Share
May 16 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
89,096 -2.6%
$801,864 $9.06 P/Share
May 15 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
5,147 -0.15%
$46,323 $9.05 P/Share
May 15 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
5,147 -0.15%
$46,323 $9.05 P/Share
May 14 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
5,757 -0.17%
$51,813 $9.01 P/Share
May 14 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
5,757 -0.17%
$51,813 $9.01 P/Share
May 07 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
100,000 -2.87%
$900,000 $9.34 P/Share
May 07 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
100,000 -2.87%
$900,000 $9.34 P/Share
Apr 23 2024
Richard E Lowenthal PRESIDENT AND CEO
BUY
Exercise of conversion of derivative security
Indirect
130,993 +1.9%
$130,993 $1.14 P/Share
Apr 23 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
BUY
Exercise of conversion of derivative security
Direct
130,993 +1.9%
$130,993 $1.14 P/Share
Apr 19 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
BUY
Exercise of conversion of derivative security
Indirect
188,491 +2.16%
$188,491 $1.14 P/Share
Apr 16 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
100,000 -2.79%
$900,000 $9.28 P/Share
Apr 16 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
100,000 -2.79%
$900,000 $9.28 P/Share
Apr 09 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
100,000 -2.76%
$900,000 $9.28 P/Share
Apr 09 2024
Richard E Lowenthal PRESIDENT AND CEO
SELL
Open market or private sale
Indirect
100,000 -2.76%
$900,000 $9.28 P/Share
Mar 27 2024
Ra Capital Management, L.P.
BUY
Open market or private purchase
Indirect
505,954 +4.84%
$4,553,586 $9.79 P/Share
Mar 26 2024
Ra Capital Management, L.P.
BUY
Open market or private purchase
Indirect
457,745 +4.62%
$4,119,705 $9.55 P/Share
Mar 25 2024
Ra Capital Management, L.P.
BUY
Open market or private purchase
Indirect
437,600 +4.64%
$3,938,400 $9.06 P/Share
Mar 25 2024
Sarina Tanimoto CHIEF MEDICAL OFFICER
SELL
Open market or private sale
Indirect
95,267 -2.56%
$857,403 $9.12 P/Share
View All Transactions

Last 12 Months Summary

Buy / Acquisition
9.98M Shares
From 7 Insiders
Open market or private purchase 8.94M shares
Exercise of conversion of derivative security 1.04M shares
Sell / Disposition
1.81M Shares
From 3 Insiders
Open market or private sale 1.81M shares

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX